These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14236841)

  • 1. DELADROXATE FOR THE PREVENTION OF OVULATION.
    RUTHERFORD RN; BANKS AL; COBURN WA
    Fertil Steril; 1964; 15():648-52. PubMed ID: 14236841
    [No Abstract]   [Full Text] [Related]  

  • 2. OVULATION INHIBITION WITH A LONG-ACTING PARENTERAL PROGESTOGEN-ESTROGEN COMBINATION.
    TAYMOR ML; PLANCK S; YAHIA C
    Fertil Steril; 1964; 15():653-60. PubMed ID: 14236842
    [No Abstract]   [Full Text] [Related]  

  • 3. Ovulation inhibition with a log-acting injectable. II. The cycling effects of varying progestagen-estrogen combinations.
    Rizkallah TH; Taymor ML
    Am J Obstet Gynecol; 1966 Jan; 94(2):161-4. PubMed ID: 5900652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid excretion in users of the injectable combined oestrogen progestogen preparation, deladroxate.
    Zaki K; Younis N; Nour H
    Egypt Popul Fam Plann Rev; 1971 Dec; 4(2):1-5. PubMed ID: 12255961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial menstrual cycles induced in ovulating women by monthly injection of progestogen-estrogen.
    Reifenstein EC; Pratt TE; Hartzell KA; Shafer WB
    Fertil Steril; 1965; 16(5):652-62. PubMed ID: 5833973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Response of peripheral receptors to the parenteral administration of an association of dihydroxyprogesterone acetophenide and estradiol-3 benzoate-17-n-butyrate. Preliminary note].
    Selvaggi L; Putignano G
    Minerva Ginecol; 1975 Dec; 27(12):961-3. PubMed ID: 778679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of estrus, time of ovulation and fertilization rate in beef heifers synchronized with dihydroxyprogesterone acetophenide.
    Wiltbank JN; Shumway RP; Parker WR; Zimmerman DR
    J Anim Sci; 1967 Jul; 26(4):764-7. PubMed ID: 6076868
    [No Abstract]   [Full Text] [Related]  

  • 8. Deladroxate: a one-a-month intramuscular contraceptive.
    Bernell James WF
    J Natl Med Assoc; 1968 Jul; 60(4):314-7. PubMed ID: 5661206
    [No Abstract]   [Full Text] [Related]  

  • 9. [Single monthly injection for contraception].
    Artner J; Friedrich F
    Geburtshilfe Frauenheilkd; 1970 Jun; 30(6):554-64. PubMed ID: 5475938
    [No Abstract]   [Full Text] [Related]  

  • 10. Endometrial histology and parentereal estrogen-progestogen administration.
    Czernobilsky B; Garcia CR; Wallach EE
    Fertil Steril; 1969; 20(1):75-90. PubMed ID: 5762553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical test with a prolonged-action estrogen-progesterone combination administered intramuscularly].
    Mateos Cándano M; Ochoa Bernal MR; Ruiz Moreno JA
    Ginecol Obstet Mex; 1969 Sep; 26(155):275-82. PubMed ID: 5402846
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of the acetophenide derivative of 16-alpha, 17-alpha-dihydroxyprogesterone and estradiol on the skeletons of rats and mice.
    Simmons DJ
    Am J Obstet Gynecol; 1969 Apr; 103(7):1002-18. PubMed ID: 5774667
    [No Abstract]   [Full Text] [Related]  

  • 13. CLINICAL AND LABORATORY ASSESSMENT OF A NEW PROGESTATIONAL AGENT.
    DORAN TA; HARKINS JL; GORNALL AG; THOMPSON DW
    Can Med Assoc J; 1964 Oct; 91(17):900-7. PubMed ID: 14199821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological study of the human ovary and mammary gland under the long-term effect of progestational agents.
    Zañartu J; Pupkin M; Rosenberg D; Dabancens A; Mendez G; Rodriguez Bravo R; Guerrero R
    Acta Eur Fertil; 1973 Dec; 4(4):187-201. PubMed ID: 4137069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of ovulation by a depot injection].
    Rodríguez Argüelles J; Ruiz Velasco V
    Ginecol Obstet Mex; 1969 May; 24(151):471-7. PubMed ID: 5347653
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of a new combination: dihydroxyprogesterone acetophenide and estradiol-3-benzoate-17 isobutyrate in gynecology].
    Cittadini E; Catalano G
    Riv Ostet Ginecol Prat Med Perinat; 1973-1974; 54(10):506-12. PubMed ID: 4620236
    [No Abstract]   [Full Text] [Related]  

  • 17. THE INHIBITION OF OVULATION WITH ORAL PROGESTATIVE SUBSTANCES.
    KAISER R
    Int J Fertil; 1964; 9():87-93. PubMed ID: 14106272
    [No Abstract]   [Full Text] [Related]  

  • 18. [Synthetic studies of contraceptive drugs. II. The synthesis of 16 alpha, 17 alpha-dihydroxyprogesterone acetophenide (author's transl)].
    Han DG; Qiang ZY; Zhu LY; Wang ZR; Chen JM
    Yao Xue Xue Bao; 1980 Dec; 15(12):725-9. PubMed ID: 7257798
    [No Abstract]   [Full Text] [Related]  

  • 19. CIRCULATION, BLOOD COAGULATION, AND CLINICAL OBSERVATIONS DURING HORMONAL SUPPRESSION OF OVULATION.
    BREHM H
    Int J Fertil; 1964; 9():45-56. PubMed ID: 14106268
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modification of the endometrium during combined therapy with dihydroxyprogesterone acetophenide and estradiol-3-benzoate-17-n-butyrate].
    Minucci D; Arreghini G; Rabasso A
    Riv Ostet Ginecol Prat Med Perinat; 1973-1974; 54(10):497-505. PubMed ID: 4807299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.